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The rat acute phase protein α2-macroglobulin (α2M) plays an 
important role in the restoration of disrupted homeostasis by inhibiting 
different types of non-specific proteases and facilitating the transport of 
cytokines, growth factors and hormones. Previously, we observed that 
administration of α2M to experimental animals prior to the infliction of life-
threatening trauma in the form of scalding or total-body irradiation, 
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significantly improved their survival rates. The aim of the present work was 
to evalute the radioprotective effect on blood cells of α2M that, when 
administered 30 min before irradiation with 6.7 Gy (LD50/30), provides 
100% survival of experimental animals where in unprotected irradiated rats 
the said dose results in 50% lethality. We observed that rats pretreated with 
α2M, after an initial decline, exhibited complete recovery of the leukocyte 
count due to the preservation of bone marrow cells, observed as a stable 
mitotic index. In untreated irradiated rats the decrease of the mitotic index 
reflected the significant destruction of bone marrow cells that resulted in a 
protracted decline in the leukocyte count. We conclude that the 
radioprotection provided by α2M was in part mediated through 
cytoprotection of new blood cells produced in the bone marrow. 
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INTRODUCTION  
 
The deleterious effects of ionizing radiation are mediated through direct 
deposition of energy to biological molecules and indirectly through generation of 
highly reactive free radicals (NAIR et al., 2001). Exposure to ionizing radiation 
induces the production of reactive oxygen species (ROS) which include superoxide, 
hydroxyl radicals, singlet oxygen, and hydrogen peroxide. Free radicals react with 
DNA, RNA, proteins, and membranes, resulting in cell dysfunction and death. 
Radiation sickness, also referred to as the acute radiation syndrome (ARS), is a 
serious illness that occurs when the entire body (or most of it) receives a high dose of 
radiation over a short period of time (WASELENKO et al., 2004). There are three types 
of ARS syndromes: the bone marrow or hematological syndrome, gastrointestinal 
and the cardiovascular/central nervous system syndromes. The bone marrow 
syndrome is characterized by anorexia, fever and a decrease in all blood cell types, 
the gastrointestinal syndrome includes diarrhea, fever, dehydration and electrolyte 
imbalance and the central nervous system syndrome is characterized by damage to 
cells that do not reproduce, such as nerve cells (WASELENKO et al., 2004). 
Since ionizing radiation causes cell dysfunction and mortality, extensive 
research is devoted to the development of effective radioprotective compounds. 
(GANDHI and NAIR, 2004) that would diminish radiation injury in living organisms 
(NAIR et al., 2001). Radioprotective compounds are very important for the 
prevention of complications after radiotherapy of cancer patients and in treating 
patients after accidental radiation exposure. At a present, a number of synthetic 
radioprotective compounds are used in radiotherapy (GRDINA et al., 2002). Aside 
from these compounds, certain adaptogens – natural nontoxic products that produce 
a nonspecific response in the body that increases resistance and restores homeostasis 
– stimulate radioresistance and are also considered as radioprotectors (LIVESEY and 
REED, 1987; NAIR et al., 2001). Previously, we observed that the administration of 
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the rat acute phase (AP) protein α2-macroglobulin (α2M) improves the survival of 
experimental animals, both after a lethal scalding (ŠEVALJEVIĆ et al., 1994) and total-
body irradiation (ŠEVALJEVIĆ et al., 2003). In view of the important role of α2M in 
the restoration of homeostasis during the AP response (MIHAILOVIĆ et al., 2007; 
USKOKOVIĆ et al., 2007), we concluded that in the rat α2M behaved as an adaptogen 
with a radioprotective function. α2M is a tetrameric, disulfide-rich plasma 
glycoprotein (SOTTRUP-JENSEN, 1989). Some of its functions, such as inhibition of 
different types of non-specific proteases and transport of cytokines, growth factors 
and hormones (BORTH, 1992) are well established, however, the molecular 
mechanisms that underlie the significant improvement of survival after irradiation 
exposure by exogenously administered α2M remain largely unknown. 
In the present work we examined further the effects of α2M in 
radioprotection on the survival rate, the leukocyte count in peripheral blood and on 
the mitotic index of bone marrow as the most radiosensitive tissue, during a four 
week follow-up period in rats with exogenously applied α2M. 
 
MATERIALS AND METHODS 
Animals 
Experiments were performed on 2.5 month-old adult male albino rats 
weighting 220-250 g of Wistar strain. All the animal procedures were approved by 
the Committee for Ethical Animal Care and Use of the Institute for Biological 
Research, Belgrade, which acts in accordance with the Guide for the Care and Use of 
Laboratory Animals, published by the US National Institute of Health (NIH 
Publication No. 85/23, revised in 1986). 
 
Experimental protocol 
Rats were whole body X irradiated using a Philips linear accelerator SL 75-
80, 8 MeV with 6.7 Gy (LD50/30) at a rate of 3.4 Gy/min. Ten animals were placed in 
a Plexiglas container divided into 10 chambers. The container was covered with a 1 
cm-thick Plexiglas sheet. The animals were exposed to radiation at 100 cm distance 
from the source. α2M was administered i.p. (4.5 mg in a saline solution) 30 min 
before irradiation. Rats from the unprotected control group were injected with the 
same volume of saline solution 30 min prior to irradiation with 6.7 Gy. The control 
rats proper (referred to as the "intact control"), were injected with the same volume 
of saline solution. The three experimental groups each contained 30-50 rats. 
The number of surviving rats were recorded for 4 weeks after irradiation, 
the standard follow-up period for evaluating biological parameters during the ARS. 
Peripheral leukocytes were measured with Hemocount ERP-9 (Ortho Diagnostic 
System, Germany). 
 
Isolation of α2M 
α2M was isolated from the sera of rats during the AP response when the 
concentration of α2M undergoes a dramatic increase. The AP response was induced 
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by an i.p. administration of turpentine oil (200 µl/rat). The sera were collected 24 h 
after injection, pooled and sequentially fractionated with dextran sulphate, DEAE 
cellulose chromatography and by gel filtration as described by OKUBO et al. (1981). 
The purity of the isolated α2M was checked by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE). Preparations that generated a 
single protein band after electrophoresis were further processed as described above 
for subsequent injection into rats. 
 
Metaphase chromosome analysis 
Animals were injected intraperitoneally with colchicine solution (1µg/1g) 1 
h before sacrifice. Both femurs were removed and the ends of each femur were cut 
off. Bone marrow cavity were washed out, with 9 ml pre-warmed (37˚C) hypotonic 
solution (0.075M KCl) and obtained cells were resuspended and incubated at 37oC 
for 25 minutes, then spin at 1500 rpm for 7 min. Supernatant was removed and the 
pellet was resuspended in freshly prepared 3:1 fixative (methanol [100%]:glacial 
acetic acid). This step was repeated two times. Total time of the fixation was 30 
minutes. At the last step cells were resuspended in a small amount of fixative (about 
0.5ml). Slides were made using flame dried method and stained 15 min. in 10% 
Giemsa solution in Sorensen's phosphate buffer. 
 
Mitotic index 
In order to analyse cytotoxic activity of irradiation and radioprotective 
activity of α2M mitotic index was calculated in bone marrow cells as the percentage 
of dividing cells of the total number of counted cells. 
 
Statistical method 
The data were expresed as means and standard errors from four separate 
experiments. The χ2 test was used to compare obtained differences in the values of 
mitotic indexes among experimental  and control groups (Statistics ver. 5). 
 
RESULTS 
 
The radioprotective efficacy of α2M was examined by comparing the 
survival times of rats that received α2M 30 min before irradiation with 6.7 Gy and 
unprotected irradiated rats (Figure 1). The administration of α2M effectively raised 
its plasma concentration about 15 fold from the basal value. The survival rates were 
recorded for 28 days. Rats from both groups survived the 1st post-irradiation week, 
however, at the end of the 2nd week, the number of surviving rats in the irradiated 
control group decreased to about 50%, more or less the number of animals that 
remained until the end of the follow-up period. In contrast, the pretreatment with 
α2M provided 100% protection. 
Peripheral blood leukocytes are the most sensitive target for irradiation. 
Their number falls rapidly in proportion to the dose of exposure. The effectiveness of 
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α2M administration on the ensuing leukocyte replenishment was assessed by 
measuring the number of peripheral blood leukocytes.  
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Figure 1. The effects of alpha2-macroglobulin on the survival of rats exposed to total body 
irradiation. Adult rats were exposed to whole body irradiation with 6.7 Gy (LD50/30). 
30 min before radiation exposure the rats either received an i.p. injection of 4.5 mg 
alpha2-macroglobulin in saline (α2M) or only saline (Gy). Each group consisted of 
30-50 rats. The values represent means ± S.E.M. from four separate experiments. 
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Figure 2. The effects of alpha2-macroglobulin on leukocyte counts after total body irradiation. 
Adult male were exposed to whole body irradiation with 6.7 Gy (LD50/30). 30 min 
before radiation exposure the rats either received an i.p. injection of 4.5 mg alpha2-
macroglobulin in saline (α2M) or only saline (Gy). Each group consisted of 30-50 
rats. The number of leukocytes is expressed relative to the control (100%). The 
values represent means ± S.E.M. from four separate experiments. 
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After exposure to 6.7 Gy, in both experimental groups the leukocyte count 
decreased to about 40% of the initial value by the 1st day (Figure 2), and by the end 
of the 1st week the leukocyte count was at its lowest. In the irradiated control group 
the leukocyte count fell to just below 10% of the initial value whereas in α2M-
pretreated groups the leukocyte count decreased to about 20% of the control value. 
During the 2nd and 3rd weeks a gradual recovery of the number of leukocytes was 
observed in all groups, and at the end of the follow-up period the number of 
leukocytes rose to about 90% of the control level in both the surviving control 
irradiated and α2M-pretreated groups. Clearly, α2M provided increased leukocyte 
protection and allowed for improved leukocyte recovery. 
The bone marrow contains hematopoietic stem cell that give rise to the 
three classes of blood cells found in the circulation: leukocytes, erythrocytes and 
thrombocytes. The number of differentiated cells in the peripheral blood is 
proportional to the level of bone marrow protection, representing a very important 
parameter of survival after irradiation. Bone marrow cells were examined for mitotic 
activity by scoring the number of cells in mitosis as described in the Materials and 
Methods. The mitotic index is presented on Figure 3. 
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Figure 3. The effect of alpha2-macroglobulin on the mitotic index of bone marrow cells after 
total body irradiation. Adult male rats were exposed to whole body irradiation with 
6.7 Gy (LD50/30). 30 min before radiation exposure the rats either received an i.p. 
injection of 4.5 mg alpha2-macroglobulin in saline (α2M) or only saline (Gy); C-
intact control. Each group consisted of 30-50 rats. The values represent means ± 
S.E.M. from four separate experiments. 
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On the 1st day after irradaition the mitotic index in unprotected animals was 
only 12% of the value observed for intact control (X2=149.19, p<0.001). At the end 
of the 2nd postirradaition week, the mitotic index increased to 70% of the control 
level, but it was still significantly different from the control (X2=10.08, p<0.001). In 
α2M-pretreated animals the mitotic index did not change on 1st post-irradiation day in 
comparison to control group (X2=0.02, p=0.880). At the end of the 2nd postirradaition 
week, the mitotic index in this experimental group was even slightly above the 
control level, but statisticaly unsignificant (X2=1.99, p=0.159). 
 
DISCUSSION 
 
α2M is a major AP protein in rats (BAUMANN and GAULDIE, 1994). During 
the AP response, a systemic reaction of organism against a variety of stress stimuli 
ranging from inflammation to tissue injury (BAUMANN and GAULDIE, 1994), the 
serum concentration of α2M increases several fold. Evidence has been provided 
which implicates the α-globulin fraction (19S) (containing α2M) in the recovery of 
mice from radiation damage. The α-globulin fraction has been shown to enhance the 
regeneration of haematopoietic cells (HANNA et al., 1976) and lymphopoietic cells 
(BERENBLUM et al., 1968) in X-irradiated mice. Cytological studies of the 
haematopoietic recovery indicated that the injection of α-globulin fraction into 
irradiated mice enhanced the recovery, both in time and magnitude, of the granuloid, 
lymphocyte and lymphocyte-like elements of the bone marrow, as well as of 
leucocytes in the peripheral blood. The bone marrow, together with lymphoid tissue, 
the gastrointestinal epithelium, gonads and embryonic tissues, is highly 
radiosensitive. In the present study, rats from the unprotecdted irradiated group 
displayed the highest mortality rate within two weeks of X-irradiation. Up to the end 
of the 2nd week after irradiation, animals from this group exhibited decreased 
leukocyte counts, whereas the pretreatment with α2M-pretreatment provided full 
survival and restoration of leukocyte numbers by the end of the follow-up period. 
In untreated irradiated animals, the number of leukocytes decreased rapidly 
after irradiation exposure whereas in the α2M-pretreated animals during the followed 
up period it increased. Compared to the intact control, the mitotic index in the bone 
marrow of α2M-pretreated animals remained almost unchanged during the critical 
two week period after irradiation. The lowest mitotic index in unprotected animals 
was observed on the 1st post-irradiation day. This dramatic decrease of the mitotic 
index on the 1st post-irradiation day in the unprotected group was probably 
responsible for the high level (50%) of mortality. The recovery of the mitotic index 
observed at the end of the 2nd week in unprotected irradiated animals is a reflection 
of the physiological state of rats possessing increased chances of surviving the ARS. 
Recovery of bone marrow cells after irradiation is possible if at least 10% of the cells 
survive irradiation exposure (STROBER, 1984). In contrast to the unprotected 
irradiated animals that exhibited a high (50%) mortality and incomplete recovery of 
the bone marrow during the follow-up period, the α2M-pretreated animals displayed 
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100% survival that was accompanied by a high mitotic index as a result of α2M-
afforded protection on the bone marrow. 
One aspect of the radioprotective efficacy of α2M could be attributed to its 
unique ability to inhibit all classes of proteases in circulation (SOTTRUP-JENSEN, 
1989, BORTH, 1992). Irradiation induces primary oxidative damage of biomolecules, 
including lipids, proteins, and DNA (NAIR et al., 2001). Damage to cellular proteins 
by oxygen free-radicals formed as a result of action of exogenous factors (radiation, 
oxidants etc.) underlies the pathogenesis of many diseases (CARNEY and CARNEY, 
1994). Thus, oxidation of amino acid residues in the active centers of enzymes could 
induce considerable alterations of their catalytic properties and, as a consequence, 
impair cellular regulatory processes. Ionizing radiation also stimulates proteolysis by 
proteases. (BARTOSZ et al., 1992). Interaction between α2M and proteases in the 
plasma and extracellular fluids involve a unique trapping mechanism by which 
proteases are incorporated covalently into the α2M molecule, diminishing their 
proteolytic effect during irradiation. 
The proliferation and differentiation of cells of the hematopoietic system 
depends directly on cytokine growth and differentiation factors produced by the host. 
Cytokines induce the growth and differentiation of many cells of connective tissue 
and immune, central nervous, vascular and endocrine systems (GUTTERMAN, 1994). 
The multiplicity of important functions that are induced by the cytokines indicates 
that these agents play essential roles in defense reactions against infections, in the 
recovery from injury and in mediating the radioprotective effect of 
immunomodulators. In addition to the importance of α2M in maintaining the 
proteinase-proteinase inhibitor equilibrium during inflammation and its antiapoptotic 
effect (BORTH, 1992), α2M also binds different acute inflammatory mediators of 
which the most important are the cytokines (TNF-α, IL-1β, IL-2, IL-6) and growth 
factors (β-NGF, PDGF-BB, TGF-β1, TGF-β2) that play essential roles in the 
regulation of cellular functions that bring about tissue repair and remodeling (JAMES, 
1990) and participate in mechanism responsible for radioprotection (NETA et al., 
1991; NETA et al., 1992). α2M was identified as a major component of the α-globulin 
fraction in the serum that modulates cell growth (HANNA et al., 1976; BERENBLUM et 
al., 1968; OLINESCU et al., 1980), and a direct link between growth factors and α2M 
was established (MATSUDA et al., 1989). 
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I z v o d 
 
Pacovski alfa2-makroglobulin (α2M) ima važnu ulogu u uspostavljanju narušene 
homeostaze inhibicijom različitih tipova nespecifičnih proteaza i olakšavajući 
transport citokina, hormona rasta i hormona. Naša ranija istraživanja su pokazala da 
administracija α2M eksperimentalnim životinjama u traumama tipa opekotine ili 
ozračivanja celog organizma značajno povećava njihovu stopu preživljavanja. Cilj 
ove studije je bio izučavanje radioprotektivne uloge α2M na ćelije kosne srži. α2M je 
apliciran 30 minuta pre ozračivanja pacova dozom od 6.7 Gy (LD50/30) X-zraka i 
omogućio je 100% preživljavanje pacova za razliku od ozračenih pacova bez 
tretmana kod kojih je smrtnost bila 50%. Rezultati su pokazali da tretiranje životinja 
sa α2M, nakon inicijalnog pada, omogućavaju potpuni oporavak broja leukocita kao 
posledica očuvanja ćelija kosne srži, što se uočava preko stabilnog mitotskog 
indeksa. Kod ozračenih pacova bez tretmana signifikantno smanjenje mitotskog 
indeksa, kao posledica narušavanja ćelija kosne srži, rezultuje i u prolongiranom 
padu broja leukocita. Na osnovu ovih rezultata može se zaključiti da se 
radioprotektivna uloga α2M delom odvija putem citoprotekcije novih krvnih ćelija u 
kosnoj srži. 
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